Monoclonal antibodies protect from staphylococcal enterotoxin K (SEK) induced toxic shock and sepsis by USA300 staphylococcus aureus

Virulence

Volumn 8, Issue 6, 2017, Pages 741-750

  Aguilar, Jorge L ^a   Varshney, Avanish K ^a   Pechuan, Ximo ^a   Dutta, Kaushik ^b   Nosanchuk, Joshua D ^a   Fries, Bettina C ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK STRUCTURAL BIOLOGY CENTER   (United States)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Staphylococcal enterotoxin B; Staphylococcal enterotoxin K; Toxic shock syndrome toxin 1

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2B; INTERLEUKIN 2; MONOCLONAL ANTIBODY; STAPHYLOCOCCAL ENTEROTOXIN K; STAPHYLOCOCCUS ENTEROTOXIN; STAPHYLOCOCCUS ENTEROTOXIN B; SUPERANTIGEN; TOXIC SHOCK SYNDROME TOXIN 1; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT; BACTERIUM ANTIBODY; ENTEROTOXIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL VIRULENCE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOTHERAPY; INTOXICATION; ION EXCHANGE CHROMATOGRAPHY; MITOGENICITY; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PERIPHERAL BLOOD MONONUCLEAR CELL; SEPTIC SHOCK; SERODIAGNOSIS; SINGLE DRUG DOSE; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE; ANIMAL; DISEASE MODEL; IMMUNOLOGY; MICROBIOLOGY; PATHOGENICITY; STAPHYLOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBODIES, BACTERIAL; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; ENTEROTOXINS; FEMALE; HUMANS; IMMUNIZATION, PASSIVE; MICE; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

EID: 84992497980     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.1080/21505594.2016.1231295     Document Type: Article

References (27)

1. van Hal SJ, Jensen SO, Vaska VL, Espedido BA, Paterson DL, Gosbell IB. Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev 2012; 25:362-86; https://doi.org/10.1128/CMR.05022-11
2. Fowler VG, Jr., Proctor RA. Where does a Staphylococ-cus aureus vaccine stand? Clin Microbiol Infect 2014; 20 (Suppl 5):66-75; https://doi.org/10.1111/1469-0691.12570
3. Becker K, Friedrich AW, Lubritz G, Weilert M, Peters G, Von Eiff C. Prevalence of genes encoding pyrogenic toxin superantigens and exfoliative toxins among strains of Staph-ylococcus aureus isolated from blood and nasal specimens. J Clin Microbiol 2003; 41:1434-9; https://doi.org/10.1128/JCM.41.4.1434-1439.2003
4. Varshney AK, Mediavilla JR, Robiou N, Guh A, Wang X, Gialanella P, Levi MH, Kreiswirth BN, Fries BC. Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York. App Envir Microbiol 2009; 75:6839-49; https://doi.org/10.1128/AEM.00272-09
5. Xu SX, McCormick JK. Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol 2012; 2:52; https://doi.org/10.3389/fcimb.2012.00052
6. Li J, Yang J, Lu YW, Wu S, Wang MR, Zhu JM. Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases. Viral Immunol 2015; 7:354-359
7. Varshney AK, Wang X, Cook E, Dutta K, Scharff MD, Goger MJ, Fries BC. Generation, characterization, and epitope mapping of neutralizing and protective monoclonal antibod-ies against staphylococcal enterotoxin B-induced lethal shock. J Biol Chem 2011; 286:9737-47; https://doi.org/10.1074/jbc.M110.212407
8. Kum WW, Chow AW. Inhibition of staphylococcal enterotoxin A-induced superantigenic and lethal activi-ties by a monoclonal antibody to toxic shock syndrome toxin-1. J Infect Dis 2001; 183:1739-48; https://doi.org/10.1086/320732
9. Bonventre PF, Thompson MR, Adinolfi LE, Gillis ZA, Parsonnet J. Neutralization of toxic shock syndrome toxin-1 by monoclonal antibodies in vitro and in vivo. Infect Immun 1988; 56:135-41;
10. Buonpane RA, Churchill HR, Moza B, Sundberg EJ, Peterson ML, Schlievert PM, Kranz DM. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med 2007; 13:725-9; https://doi.org/10.1038/nm1584
11. Lina G, Bohach GA, Nair SP, Hiramatsu K, Jouvin-Mar-che E, Mariuzza R, International Nomenclature Commit-tee for Staphylococcal S. Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis 2004; 189:2334-6; https://doi.org/10.1086/420852
12. Orwin PM, Leung DY, Donahue HL, Novick RP, Schlie-vert PM. Biochemical and biological properties of Staph-ylococcal enterotoxin K. Infect Immun 2001; 69:360-6; https://doi.org/10.1128/IAI.69.1.360-366.2001
13. Djahmi N, Messad N, Nedjai S, Moussaoui A, Mazouz D, Richard JL, Sotto A, Lavigne JP. Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital. Clin Microbiol Infect 2013; 19:E398-404; https://doi.org/10.1111/1469-0691.12199
14. Machuca MA, Sosa LM, Gonzalez CI. Molecular typing and virulence characteristic of methicillin-resistant Staphylococ-cus aureus isolates from pediatric patients in Bucaramanga, Colombia. PloS one 2013; 8:e73434; https://doi.org/10.1371/journal.pone.0073434
15. Indrawattana N, Sungkhachat O, Sookrung N, Chongsa-nguan M, Tungtrongchitr A, Voravuthikunchai SP, Kong-ngoen T, Kurazono H, Chaicumpa W. Staphylo-coccus aureus clinical isolates: antibiotic susceptibility, molecular characteristics, and ability to form biofilm. BioMed Res Int 2013; 2013:314654; https://doi.org/10.1155/2013/314654
16. Shukla SK, Karow ME, Brady JM, Stemper ME, Kislow J, Moore N, Wroblewski K, Chyou PH, Warshauer DM, Reed KD, et al. Virulence genes and genotypic associations in nasal carriage, community-associated methicillin-susceptible and methicillin-resistant USA400 Staphylococcus aureus isolates. J Clin Microbiol 2010; 48:3582-92; https://doi.org/10.1128/JCM.00657-10
17. Wu D, Li X, Yang Y, Zheng Y, Wang C, Deng L, Liu L, Li C, Shang Y, Zhao C, et al. Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired meticillin-resistant Staphylococcus aureus isolated from Chi-nese children. J Med Microbiol 2011; 60:35-45; https://doi.org/10.1099/jmm.0.023465-0
18. Aguilar JL, Varshney AK, Wang X, Stanford L, Scharff M, Fries BC. Detection and measurement of staphylo-coccal enterotoxin-like K (SEl-K) secretion by Staphy-lococcus aureus clinical isolates. J Clin Microbiol 2014; 52:2536-43; https://doi.org/10.1128/JCM.00387-14
19. Omoe K, Hu DL, Ono HK, Shimizu S, Takahashi-Omoe H, Nakane A, Uchiyama T, Shinagawa K, Imanishi K. Emetic potentials of newly identified staphylococcal enterotoxin-like toxins. Infect Immun 2013; 81:3627-31; https://doi.org/10.1128/IAI.00550-13
20. Varshney AK, Wang X, Aguilar JL, Scharff MD, Fries BC. Isotype switching increases efficacy of antibody protection against staphylococcal enterotoxin B-induced lethal shock and Staphylococcus aureus sepsis in mice. mBio 2014; 5:e01007-14; https://doi.org/10.1128/mBio.01007-14
21. Khan AA, Martin S, Saha B. SEB-induced signaling in macrophages leads to biphasic TNF-alpha. J Leukocyte Biol 2008; 83:1363-9; https://doi.org/10.1189/jlb.1007686
22. Domiati-Saad R, Lipsky PE. Staphylococcal enterotoxin A induces survival of VH3-expressing human B cells by binding to the VH region with low affinity. J Immunol 1998; 161:1257-66;
23. Perez-Novo CA, Waeytens A, Claeys C, Cauwenberge PV, Bachert C. Staphylococcus aureus enterotoxin B regulates prostaglandin E2 synthesis, growth, and migration in nasal tissue fibroblasts. J Infect Dis 2008; 197:1036-43; https://doi.org/10.1086/528989
24. Ackermann L, Pelkonen J, Harvima IT. Staphylococcal enterotoxin B inhibits the production of interleukin-4 in a human mast-cell line HMC-1. Immunology 1998; 94:247-52; https://doi.org/10.1046/j.1365-2567.1998.00508.x
25. Dutta K, Varshney AK, Franklin MC, Goger M, Wang X, Fries BC. Mechanisms mediating enhanced neutraliza-tion efficacy of staphylococcal enterotoxin B by combinations of monoclonal antibodies. J Biol Chem 2015; 290:6715-30; https://doi.org/10.1074/jbc.M114.630715
26. Ponsel D, Neugebauer J, Ladetzki-Baehs K, Tissot K. High affinity, developability and functional size: the holy grail of combinatorial antibody library generation. Mole-cules 2011; 16:3675-700; https://doi.org/10.3390/molecules16053675
27. Vaughan TJ, Williams AJ, Pritchard K, Osbourn JK, Pope AR, Earnshaw JC, McCafferty J, Hodits RA, Wilton J, Johnson KS. Human antibodies with sub-nanomolar affinities isolated from a large non-immunized phage display library. Nat Biotechnol 1996; 14:309-14; https://doi.org/10.1038/nbt0396-309